Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Kamran Alam

CFO at Taysha Gene Therapies, Inc. (TSHA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $493K

Reported trades

Filed Stock Type Shares Price Value Since
Feb 6SEC TSHATaysha Gene Therapies, Inc. Sell 1,6551,442,131 held (−0%) $4.52 $7K -19.9%
Jan 27SEC TSHATaysha Gene Therapies, Inc. Sell 78,9681,467,635 held (−5%) $4.75 $375K -23.8%
Jan 27SEC TSHATaysha Gene Therapies, Inc. Sell 23,8491,443,786 held (−2%) $4.61 $110K -21.5%